Physician

Adam E Pflugrath, MD

According to 2025 Medicare claims, Adam Pflugrath, MD (NPI: 1134515042) practices ophthalmology in the Greenville-Anderson-Greer, SC market, with the plurality of this provider's patient population coming from Greenville, SC. This provider's primary affiliated billing organization is JERVEY EYE GROUP, PA (NPI: 1992775696; TIN: 570996196) and primary practice location at 29605-4528. Pflugrath is affiliated with the CVS ACO (ACO ID: A5407) and CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under both the MSSP and REACH models.

Pflugrath's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,034 traditional Medicare patients, billed 144,766 HCPCS/CPT codes, and received $5,176,181 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 485 prescription claims across 217 beneficiaries totaling $41,052 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 27 records totaling $656. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $969,935 to $5,176,181. Similarly, Part D prescription costs have moved sharply higher in recent years, from $10,613 to $41,052. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.2M2019 Medicare payment: $969,935 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,380,549 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,149,253 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,942,126 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,188,115 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,176,181 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20196212,374$969,935
20201,0086,885$2,380,549
20218474,204$1,149,253
202273910,752$1,942,126
202390261,700$3,188,115
20241,034144,766$5,176,181

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$23K$45K2016 Drug cost: $10,613 (USD; Tot_Drug_Cst)2017 Drug cost: $20,645 (USD; Tot_Drug_Cst)2018 Drug cost: $45,212 (USD; Tot_Drug_Cst)2019 Drug cost: $9,609 (USD; Tot_Drug_Cst)2020 Drug cost: $2,710 (USD; Tot_Drug_Cst)2021 Drug cost: $2,860 (USD; Tot_Drug_Cst)2022 Drug cost: $32,139 (USD; Tot_Drug_Cst)2023 Drug cost: $40,019 (USD; Tot_Drug_Cst)2024 Drug cost: $41,052 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
201667157$10,613
2017112286$20,645
2018171543$45,212
201949106$9,609
20203968$2,710
20213469$2,860
2022138282$32,139
2023182374$40,019
2024217485$41,052

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye5082,341$89
92014Established patient complete exam of visual system8621,263$80
92134Imaging of retina9793,162$28
J2777Injection, faricimab-svoa, 0.1 mg408127,140$27
92250Photography of the retina486627$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium231,224$11,624
IlevroNepafenac22701$9,627
Bromfenac SodiumBromfenac Sodium331,396$5,568
Prednisolone AcetatePrednisolone Acetate532,309$2,495
DifluprednateDifluprednate22471$2,091

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.27$656Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam E. Pflugrath, MD?

Tedicare shows public-source Medicare data for Adam E. Pflugrath, MD (NPI 1134515042), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam E. Pflugrath, MD have ACO affiliation data?

Adam E. Pflugrath, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407) and CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Adam E. Pflugrath, MD?

Adam E. Pflugrath, MD is linked to JERVEY EYE GROUP, PA (billing NPI 1992775696) in the available physician profile data.

Does Adam E. Pflugrath, MD have Open Payments data?

Adam E. Pflugrath, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.